Wucheng Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wucheng Tao has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Huakun Shangguan
Fujian Key Laboratory of Cognitive Function and Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China
2 shared publications Le Guan
Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Pain Research Institute, Fujian Medical University, Fuzhou, Fujian, China
2 shared publicationsAiqin Chen
Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Pain Research Institute, Fujian Medical University, Fuzhou, Fujian, China
1 shared publicationBin Wu
Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China
1 shared publicationBinbin Ye
School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China
1 shared publicationBing-Jie Wei
The School of Nursing, Fujian Medical University, Fuzhou, China
1 shared publication
Latest Publications
- 25 February 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (7) , 3758-3774
Dual regulatory roles of CPT1C in chronic stress-induced depression-related outcomes
Regulation of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor (AMPAR) function has emerged as a novel strategy for major depressive disorder (MDD); however, the underlying molecular mechanisms remain unclear. Here, we demonstrate that enhanced GluA1 depalmitoylation in the nucleus accumbens mediates depressive-like behaviors following chronic stress, and identify that the dysfunction of carnitine palmitoyltransferase 1 C (CPT1C), a depalmitoylating enzyme that specifically depalmitoylates GluA1, mediated depression-like behaviors in mice. Furthermore, dopamine D2 receptor-expressing medium spiny neurons (D2-MSN)-specific knockdown of CPT1C prevented stress-induced depression-like behaviors, and CPT1C deficiency in D1-MSN abolished the behavioral and synaptic plasticity alterations caused by fluoxetine treatment. More importantly, CPT1C is directly involved in regulating GluA1 synthesis through disinhibiting mTORC1 signaling by targeting tuberous sclerosis complex 2. Collectively, these results newly identify CPT1C as a dual regulator of GluA1 function from protein synthesis, post-translational modification to subcellular localization, and show that CPT1C may serve as a promising novel therapeutic target for MDD.
- 25 February 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (7) , 3758-3774
Dual regulatory roles of CPT1C in chronic stress-induced depression-related outcomes
Regulation of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor (AMPAR) function has emerged as a novel strategy for major depressive disorder (MDD); however, the underlying molecular mechanisms remain unclear. Here, we demonstrate that enhanced GluA1 depalmitoylation in the nucleus accumbens mediates depressive-like behaviors following chronic stress, and identify that the dysfunction of carnitine palmitoyltransferase 1 C (CPT1C), a depalmitoylating enzyme that specifically depalmitoylates GluA1, mediated depression-like behaviors in mice. Furthermore, dopamine D2 receptor-expressing medium spiny neurons (D2-MSN)-specific knockdown of CPT1C prevented stress-induced depression-like behaviors, and CPT1C deficiency in D1-MSN abolished the behavioral and synaptic plasticity alterations caused by fluoxetine treatment. More importantly, CPT1C is directly involved in regulating GluA1 synthesis through disinhibiting mTORC1 signaling by targeting tuberous sclerosis complex 2. Collectively, these results newly identify CPT1C as a dual regulator of GluA1 function from protein synthesis, post-translational modification to subcellular localization, and show that CPT1C may serve as a promising novel therapeutic target for MDD.
- Open Access
- 20 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 67
Deletion of Glutamate Delta 1 Receptor Leads to Heterogeneous Transcription and Synaptic Gene Alterations Across Brain Regions
Glutamate delta 1 receptor (GluD1) has various functional roles in the brain, such as high-frequency hearing, synapse formation and maintenance, and regulation of cognition disorders and neurodevelopmental disease. However, the underlying molecular mechanism, especially at the genetic level, remains to be elucidated. In this study, we use transcriptomics analysis to define the genetic impact of GluD1 across the brain regions in GluD1 knockout mice. Our results show that GluD1 deletion induced pronounced differences in gene expression both across the four brain regions (cortex, cerebellum, hippocampus, and striatum) and the distinct hippocampal subregions. Despite differences in transcriptional profiles, the differentially expressed genes (DEGs) across all four brain regions show significant enrichment in synaptic signaling pathways, highlighting the critical role of GluD1 in synaptic function. The GluD1 interaction network and its downstream target genes are closely linked to the pathogenesis of intellectual disability (ID) and autism spectrum disorders (ASDs). In conclusion, our work reveals that GluD1 deletion leads to brain-region-specific transcriptional changes and establishes a genetic link between the interaction network with GluD1 and the risk genes for ID and ASD.
- 20 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 67
Open AccessDeletion of Glutamate Delta 1 Receptor Leads to Heterogeneous Transcription and Synaptic Gene Alterations Across Brain Regions
Glutamate delta 1 receptor (GluD1) has various functional roles in the brain, such as high-frequency hearing, synapse formation and maintenance, and regulation of cognition disorders and neurodevelopmental disease. However, the underlying molecular mechanism, especially at the genetic level, remains to be elucidated. In this study, we use transcriptomics analysis to define the genetic impact of GluD1 across the brain regions in GluD1 knockout mice. Our results show that GluD1 deletion induced pronounced differences in gene expression both across the four brain regions (cortex, cerebellum, hippocampus, and striatum) and the distinct hippocampal subregions. Despite differences in transcriptional profiles, the differentially expressed genes (DEGs) across all four brain regions show significant enrichment in synaptic signaling pathways, highlighting the critical role of GluD1 in synaptic function. The GluD1 interaction network and its downstream target genes are closely linked to the pathogenesis of intellectual disability (ID) and autism spectrum disorders (ASDs). In conclusion, our work reveals that GluD1 deletion leads to brain-region-specific transcriptional changes and establishes a genetic link between the interaction network with GluD1 and the risk genes for ID and ASD.
- Open Access
- 29 August 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-10
Deficiency of KMT2D causes autistic-like behavior in mice and zebrafish
Kabuki syndrome type 1 is a congenital multisystem disorder caused by KMT2D mutations. While some studies suggest that KMT2D deficiency may lead to autistic-like behaviors, the role of KMT2D in social behavior remains unconfirmed due to a lack of animal model evidence. In this study, we developed a mouse knockdown model and a zebrafish knockout model to investigate the role of KMT2D in synaptic function and behavioral patterns. We also performed an RNA sequencing analysis to delve into the molecular and cellular mechanisms of KMT2D. Results showed that Kmt2d deficiency in mouse and zebrafish both exhibited autistic-like behaviors including social behaviors defects and repetitive behavior. Additionally, knockdown of Kmt2d in the mouse hippocampus decreases excitatory and increases inhibitory synaptic transmission, disrupting the excitation-inhibition balance—a hallmark of autistic-like behaviors. RNA sequencing analysis revealed that under conditions of low kmt2d expression, differentially expressed genes were associated with glutamatergic and GABAergic synapses, supporting the dysregulation of excitation-inhibition balance in the hippocampus. Taken together, our research elucidates the critical role of KMT2D in modulating animal social behavior, potentially through its impact on synaptic excitation-inhibition balance.
- 29 August 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-10
Open AccessDeficiency of KMT2D causes autistic-like behavior in mice and zebrafish
Kabuki syndrome type 1 is a congenital multisystem disorder caused by KMT2D mutations. While some studies suggest that KMT2D deficiency may lead to autistic-like behaviors, the role of KMT2D in social behavior remains unconfirmed due to a lack of animal model evidence. In this study, we developed a mouse knockdown model and a zebrafish knockout model to investigate the role of KMT2D in synaptic function and behavioral patterns. We also performed an RNA sequencing analysis to delve into the molecular and cellular mechanisms of KMT2D. Results showed that Kmt2d deficiency in mouse and zebrafish both exhibited autistic-like behaviors including social behaviors defects and repetitive behavior. Additionally, knockdown of Kmt2d in the mouse hippocampus decreases excitatory and increases inhibitory synaptic transmission, disrupting the excitation-inhibition balance—a hallmark of autistic-like behaviors. RNA sequencing analysis revealed that under conditions of low kmt2d expression, differentially expressed genes were associated with glutamatergic and GABAergic synapses, supporting the dysregulation of excitation-inhibition balance in the hippocampus. Taken together, our research elucidates the critical role of KMT2D in modulating animal social behavior, potentially through its impact on synaptic excitation-inhibition balance.
- Open Access
- 9 July 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (28)
The pathogenic factor of ZC4H2-associated rare disorder is a postsynaptic regulator for synaptic activity and cognitive function
The maintenance of excitatory synaptic activity is crucial for cognitive function and genetic mutations are responsible for the pathogenesis of related brain disorders. However, the roles of these pathogenic factors in synaptic dysregulation and cognitive malfunction are still poorly understood. In this study, a conditional knockout mouse model lacking ZC4H2 —an X-linked gene implicated in ZC4H2-associated rare disorder (ZARD) —in forebrain excitatory neurons is generated and these mice exhibit cognitive malfunction, recapitulating the intellectual disability manifestation of ZARD. Mechanistically, ZC4H2 harbors a protein interaction network with key excitatory synaptic regulators and ZC4H2 interacts directly with AMPA receptors (AMPARs) and regulates their ubiquitination at the postsynaptic sites, thereby maintaining AMPARs protein stability and synaptic expression. ZC4H2 deficiency specifically and aberrantly increases AMPAR-mediated excitatory synaptic transmission and impairs synaptic plasticity of long-term potentiation. More importantly, pharmacological treatment with perampanel, an AMPAR-specific antagonist, successfully restores the excitatory synaptic activity and cognitive function of ZC4H2-deficient mice. Together, we establish that ZC4H2 is a postsynaptic regulator for AMPARs and excitatory synaptic activity and highlight that the dysregulation of these biological processes is a crucial etiology underlying ZARD-associated intellectual disability.
- 9 July 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (28)
Open AccessThe pathogenic factor of ZC4H2-associated rare disorder is a postsynaptic regulator for synaptic activity and cognitive function
The maintenance of excitatory synaptic activity is crucial for cognitive function and genetic mutations are responsible for the pathogenesis of related brain disorders. However, the roles of these pathogenic factors in synaptic dysregulation and cognitive malfunction are still poorly understood. In this study, a conditional knockout mouse model lacking ZC4H2 —an X-linked gene implicated in ZC4H2-associated rare disorder (ZARD) —in forebrain excitatory neurons is generated and these mice exhibit cognitive malfunction, recapitulating the intellectual disability manifestation of ZARD. Mechanistically, ZC4H2 harbors a protein interaction network with key excitatory synaptic regulators and ZC4H2 interacts directly with AMPA receptors (AMPARs) and regulates their ubiquitination at the postsynaptic sites, thereby maintaining AMPARs protein stability and synaptic expression. ZC4H2 deficiency specifically and aberrantly increases AMPAR-mediated excitatory synaptic transmission and impairs synaptic plasticity of long-term potentiation. More importantly, pharmacological treatment with perampanel, an AMPAR-specific antagonist, successfully restores the excitatory synaptic activity and cognitive function of ZC4H2-deficient mice. Together, we establish that ZC4H2 is a postsynaptic regulator for AMPARs and excitatory synaptic activity and highlight that the dysregulation of these biological processes is a crucial etiology underlying ZARD-associated intellectual disability.
- 2 July 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 352, 120221
Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's disease
- 2 July 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 352, 120221
Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's disease
- Open Access
- 4 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (3) , 363
Cortical Potentiation in Chronic Neuropathic Pain and the Future Treatment
Pain, or the ability to feel pain and express the unpleasantness caused by peripheral injuries, are functions of the central nervous system. From peripheral sensory nerve terminals to certain cortical regions of the brain, activation of related neural networks underlies the sensory process. Recently, our knowledge of pain has been increasing dramatically, due to the advancement of scientific approaches. We no longer see the brain as a random matrix for pain but, rather, we are able to identify the step-by-step selective signaling proteins, neurons, and networks that preferentially contribute to the process of chronic pain and its related negative emotions, like anxiety and fear. However, there is still lacking the selective and effective drugs and methods for the treatment of chronic pain clinically. While first-line drugs for acute pain and mental diseases are also applied for the clinical management of chronic pain, their prolonged usage always causes serious side effects. In this short review, we will update and summarize the recent progress in this field and mainly focus on the roles of neural networks and synaptic mechanisms in chronic neuropathic pain. Furthermore, potential drug targets (such as plasticity-related signaling molecules, ionic channels, cytokines, and neuropeptides) and methods for the management of chronic neuropathic pain will be discussed as well. We hope this review can provide new, valuable insight into the treatment of chronic neuropathic pain.
- 4 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (3) , 363
Open AccessCortical Potentiation in Chronic Neuropathic Pain and the Future Treatment
Pain, or the ability to feel pain and express the unpleasantness caused by peripheral injuries, are functions of the central nervous system. From peripheral sensory nerve terminals to certain cortical regions of the brain, activation of related neural networks underlies the sensory process. Recently, our knowledge of pain has been increasing dramatically, due to the advancement of scientific approaches. We no longer see the brain as a random matrix for pain but, rather, we are able to identify the step-by-step selective signaling proteins, neurons, and networks that preferentially contribute to the process of chronic pain and its related negative emotions, like anxiety and fear. However, there is still lacking the selective and effective drugs and methods for the treatment of chronic pain clinically. While first-line drugs for acute pain and mental diseases are also applied for the clinical management of chronic pain, their prolonged usage always causes serious side effects. In this short review, we will update and summarize the recent progress in this field and mainly focus on the roles of neural networks and synaptic mechanisms in chronic neuropathic pain. Furthermore, potential drug targets (such as plasticity-related signaling molecules, ionic channels, cytokines, and neuropeptides) and methods for the management of chronic neuropathic pain will be discussed as well. We hope this review can provide new, valuable insight into the treatment of chronic neuropathic pain.
- Open Access
- 4 January 2023
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 1022463
Research hotspots and trends in visceral pain research: A global comprehensive bibliometric analysis
Background: Visceral pain is a complex and heterogeneous disorder that is considered more prominent compared to somatic pain, due to its multiple and complex causes and accompanying emotional and mood disorders. Research has become increasingly extensive over the years, but a bibliometric analysis of this field is lacking. The aim of this study was to analyze global research trends in visceral pain over the past 40 years through visual analysis.Methods: We conducted a comprehensive search of the literature from January 1981 to December 2021 using the Web of Science core database. The medical subject term ‘visceral pain’ was searched. We used CiteSpace and VOSviewer for bibliometric analysis and network visualization, including top-ranked authors, keywords, research collaborations, and literature co-occurrence network analysis.Results: A total of 5,047 articles were included in the analysis. The number of articles on visceral pain has continued to grow steadily over the past 40 years. The United States (1,716 articles), University of California (159 articles), and Neurogastroenterology and Motility (276 articles) were the country, institution, and journal with the most publications, respectively. Keyword analysis showed that inflammation, visceral hypersensitivity, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), anxiety, and quality of life were the research trends and priorities in this research field.Conclusion: Visceral pain-related research has received increasing attention in recent decades. However, there are still many unresolved issues in the field of visceral pain, such as the specific molecular mechanisms and clinical treatments between visceral pain and inflammation, IBD, IBS, anxiety, and quality of life, which may require further exploration based on modern scientific and technological means and more basic research, especially for the therapeutic targets of visceral pain, which may become a hot spot for future research and provide guidance for the treatment of clinical diseases related to visceral pain.
- 4 January 2023
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 1022463
Open AccessResearch hotspots and trends in visceral pain research: A global comprehensive bibliometric analysis
Background: Visceral pain is a complex and heterogeneous disorder that is considered more prominent compared to somatic pain, due to its multiple and complex causes and accompanying emotional and mood disorders. Research has become increasingly extensive over the years, but a bibliometric analysis of this field is lacking. The aim of this study was to analyze global research trends in visceral pain over the past 40 years through visual analysis.Methods: We conducted a comprehensive search of the literature from January 1981 to December 2021 using the Web of Science core database. The medical subject term ‘visceral pain’ was searched. We used CiteSpace and VOSviewer for bibliometric analysis and network visualization, including top-ranked authors, keywords, research collaborations, and literature co-occurrence network analysis.Results: A total of 5,047 articles were included in the analysis. The number of articles on visceral pain has continued to grow steadily over the past 40 years. The United States (1,716 articles), University of California (159 articles), and Neurogastroenterology and Motility (276 articles) were the country, institution, and journal with the most publications, respectively. Keyword analysis showed that inflammation, visceral hypersensitivity, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), anxiety, and quality of life were the research trends and priorities in this research field.Conclusion: Visceral pain-related research has received increasing attention in recent decades. However, there are still many unresolved issues in the field of visceral pain, such as the specific molecular mechanisms and clinical treatments between visceral pain and inflammation, IBD, IBS, anxiety, and quality of life, which may require further exploration based on modern scientific and technological means and more basic research, especially for the therapeutic targets of visceral pain, which may become a hot spot for future research and provide guidance for the treatment of clinical diseases related to visceral pain.
- Open Access
- 26 December 2022
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 39 (9) , 1333-1347
WDR62-deficiency Causes Autism-like Behaviors Independent of Microcephaly in Mice
Brain size abnormality is correlated with an increased frequency of autism spectrum disorder (ASD) in offspring. Genetic analysis indicates that heterozygous mutations of the WD repeat domain 62 (WDR62) are associated with ASD. However, biological evidence is still lacking. Our study showed that Wdr62 knockout (KO) led to reduced brain size with impaired learning and memory, as well as ASD-like behaviors in mice. Interestingly, Wdr62 Nex-cKO mice (depletion of WDR62 in differentiated neurons) had a largely normal brain size but with aberrant social interactions and repetitive behaviors. WDR62 regulated dendritic spinogenesis and excitatory synaptic transmission in cortical pyramidal neurons. Finally, we revealed that retinoic acid gavages significantly alleviated ASD-like behaviors in mice with WDR62 haploinsufficiency, probably by complementing the expression of ASD and synapse-related genes. Our findings provide a new perspective on the relationship between the microcephaly gene WDR62 and ASD etiology that will benefit clinical diagnosis and intervention of ASD.
- 26 December 2022
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 39 (9) , 1333-1347
Open AccessWDR62-deficiency Causes Autism-like Behaviors Independent of Microcephaly in Mice
Brain size abnormality is correlated with an increased frequency of autism spectrum disorder (ASD) in offspring. Genetic analysis indicates that heterozygous mutations of the WD repeat domain 62 (WDR62) are associated with ASD. However, biological evidence is still lacking. Our study showed that Wdr62 knockout (KO) led to reduced brain size with impaired learning and memory, as well as ASD-like behaviors in mice. Interestingly, Wdr62 Nex-cKO mice (depletion of WDR62 in differentiated neurons) had a largely normal brain size but with aberrant social interactions and repetitive behaviors. WDR62 regulated dendritic spinogenesis and excitatory synaptic transmission in cortical pyramidal neurons. Finally, we revealed that retinoic acid gavages significantly alleviated ASD-like behaviors in mice with WDR62 haploinsufficiency, probably by complementing the expression of ASD and synapse-related genes. Our findings provide a new perspective on the relationship between the microcephaly gene WDR62 and ASD etiology that will benefit clinical diagnosis and intervention of ASD.
- Open Access
- 29 January 2022
- Published by Elsevier in Neuroscience Letters
- Vol. 773, 136481
GABA-B receptors enhance GABA-A receptor currents by modulation of membrane trafficking in dentate gyrus granule cells
- 29 January 2022
- Published by Elsevier in Neuroscience Letters
- Vol. 773, 136481
Open AccessGABA-B receptors enhance GABA-A receptor currents by modulation of membrane trafficking in dentate gyrus granule cells
- Open Access
- 15 December 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Synaptic memory requires CaMKII
Long-term potentiation (LTP) is arguably the most compelling cellular model for learning and memory. While the mechanisms underlying the induction of LTP (‘learning’) are well understood, the maintenance of LTP (‘memory’) has remained contentious over the last 20 years. Here, we find that Ca2+-calmodulin-dependent kinase II (CaMKII) contributes to synaptic transmission and is required LTP maintenance. Acute inhibition of CaMKII erases LTP and transient inhibition of CaMKII enhances subsequent LTP. These findings strongly support the role of CaMKII as a molecular storage device.
- 15 December 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Open AccessSynaptic memory requires CaMKII
Long-term potentiation (LTP) is arguably the most compelling cellular model for learning and memory. While the mechanisms underlying the induction of LTP (‘learning’) are well understood, the maintenance of LTP (‘memory’) has remained contentious over the last 20 years. Here, we find that Ca2+-calmodulin-dependent kinase II (CaMKII) contributes to synaptic transmission and is required LTP maintenance. Acute inhibition of CaMKII erases LTP and transient inhibition of CaMKII enhances subsequent LTP. These findings strongly support the role of CaMKII as a molecular storage device.